Patent · US Active

Diffusing alpha-emitter radiation therapy for prostate cancer

US11964168B2 · kind B2 · utility

0Cited by

9References

10Claims

0Family size

Assignee

Alpha Tau Medical Ltd. · IL

Inventors

Itzhak Kelson · Tel Aviv-Yafo, IL
Yona Keisari · Ramat Gan, IL
Amnon Gat · Matan, IL
Robert Den · Cynwyd Estates, US
Ofer Magen · Hod HaSharon, IL
Vered Domankevich · Hod HaSharon, IL
Lior Arazi · Tel Aviv-Yafo, IL
Tomer Cooks · Gdera, IL
Guy Heger · Ramat Gan, IL
Mirta Duman{hacek over (c)}ić · Beer Sheva, IL
Ishai Luz · Gevim, IL
Maayan Hedva Vatarescu · al-Araqeeb, IL

Key dates

Filing date	Jan 9, 2023
Grant date	Apr 23, 2024
Priority date	—
Expiry date	Jan 9, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N2005/1087
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

A method for treating a tumor, comprising identifying a tumor as a prostate cancer tumor and implanting in the tumor identified as a prostate cancer tumor, at least one diffusing alpha-emitter radiation therapy (DaRT) source with a suitable radon release rate and for a given duration, such that the source provides during the given duration a cumulated activity of released radon between 7 Mega becquerel (MBq) hour and 14.7 MBq hour, per centimeter length.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.